Replies to post #69141 on Biotech Values

[DewDiligence]

>The only way out is for INCY to do some significant partnering/outlicensing to raise cash and reduce the burn, which I expect they will do.<

If they could bring back the genomics bubble circa 1999-2000, wouldn’t that do the trick? :- )

[poorgradstudent]

incy:

>>>I added INCY at 2.36.<<

Well, a 42% gain in one week isn't half bad, pgs.<

Then you'll be happier with my add at $2 :-)

http://siliconinvestor.advfn.com/readmsg.aspx?msgid=25195696


Notwithstanding my flukes in the trading department, I do think you're correct in regards to the company.

Part of my confidence is that I do think they will partner. They appear competent at producing drug candidates, and for an unprofitable biotech, they do relatively thorough phase I/II trials. I hope greed doesn't overcome them.



===

I did sell shares at 3.26 on wednesday to reduce the cost on the 2 and 2.36 shares to zero. No sense looking a gift horse in the mouth in this environment.